Frazier Lifesciences Acquisition Corporation Unit
FLACU
FLACU was delisted on the 22nd of November, 2022.
23 hedge funds and large institutions have $39.9M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
12% less funds holding
Funds holding: 26 → 23 (-3)
14% less capital invested
Capital invested by funds: $46.4M → $39.9M (-$6.5M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$6.99K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$4.44M |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$1.3M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$723K |
| 4 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$300K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$107K |
FLACU Hedge Fund Activity: Q4 2021 in Review
23 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q4 2021, worth a combined $39.9M — down 14% from $46.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FLACU and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Walleye Capital, adding an estimated $6.99K. The largest seller was Ensign Peak Advisors, exiting entirely with an estimated $4.44M sold.
- 23 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q4 2021, down from 26 in Q3 2021.
- Funds reported $39.9M of Frazier Lifesciences Acquisition Corporation Unit stock for Q4 2021, down 14% quarter-over-quarter.
- 1 fund opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q4 2021 and 4 closed out, a net change of -3 holders.
- The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q4 2021 was Walleye Capital, an estimated $6.99K added.
- The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q4 2021 was Ensign Peak Advisors, an estimated $4.44M sold.
Based on aggregated 13F filings for Q4 2021.